Publications
- 1) Rummo OO, Carmellini M, Rostaing L, Kazeem G, et al (2017) ADHERE: randomized controlled trial comparing renal function in de novo kidney transplant recipients receiving prolonged-release tacrolimus plus mycophenolate mofetil or sirolimus. Transpl Int. 30:83-95
- 2) Mourad G, Glyda M, Albano L, Kazeem G, et al (2016) Incidence of posttransplantation diabetes mellitus in de novo kidney transplant recipients receiving prolonged-release tacrolimus-based immunosuppression with 2 different corticosteroid minimization strategies: ADVANCE, a randomized controlled trial. Transplantation Epub Aug 19
- 3) Ditrrich C, Vinolas N, Kazeem G, et al. (2014) A randomized phase II study of permetrexed versus pemetrexed + erlotinib as a second-line treatment for locally advanced non-squamous non-small cell lung cancer. European Journal of Cancer 50:1571-80
- (4) Del Mastro L, Fabi A, Mansutti M, Kazeem G, et al. (2013) Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparsion of different schedules and treatments. BMC Cancer 13:164
- (5) Freathy RM, Kazeem GR, Morris RW, et al. (2011). Genetic variation at CHRNA5-CHRNA3-CHRNB4 interacts with smoking status to influence body mass index. Int J Epidemiol,40(6): 1617-28
- 6) Kazeem GR, Bacanu S, Nelson MR et al. (2009) Use of genome-wide association studies to identify predictors of drug efficacy in clinical development. Proceedings of the Joint Statistical Meeting of the American Statistical Association
- 7) Kazeem GR, Cox C, Aponte J, Brazel C, et al. (2009) High resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients. Pharmacogenet Genomics 19(9): 661-5
- 8) Tarnow L, Vionnet N, Kazeem GR, et al. (2007) European Rational Approach for the Genetics of Diabetic Complications – EURAGEDIC patient populations and strategy. Nephrol Dial Transplant 23(1): 161-8
- 9) Vionnet N, Tregouet D, Kazeem G, et al. (2006) Analysis of 14 candidate genes for diabetic nephropathy on chromosome 3q in European populations Diabetes 55(11)3166-74
- 10) KazeemGR and Farrall M (2005) Integrating Case-control and TDT studies Ann Hum Genet 69:329-335
- 11) Lee YW, Oh VM, Garcia E, Kazeem GR, et al. (2004) Haplotypes of beta2-adrenergic receptor gene are associated with essential hypertension in a Singaporean Chinese population. J Hypertens 22(11): 2111-6
Business Links and Partners
- Astellas Pharmaceuticals
- Chiltern International Ltd
- Eli Lilly Pharmaceuticals
- Daiichi-Sankyo Development
- Professional Associations: RSS, PSI